NovaRock Biotherapeutics focuses on advancing healthcare through innovative biotherapeutic solutions aimed at addressing unmet medical needs. The company employs a range of sophisticated technologies, including antibody discovery and engineering platforms, which are designed to identify and optimize therapeutic antibodies. These platforms enable the development of targeted treatments that can effectively combat various diseases, enhancing the potential for successful patient outcomes.

In addition to antibody technologies, NovaRock utilizes cell line discovery platforms to support the production of high-quality biopharmaceuticals. This comprehensive approach allows the company to streamline the development process, ensuring that their products are not only innovative but also affordable for global patients. By integrating these advanced technologies, NovaRock is committed to delivering superior medical solutions that meet the demands of the healthcare market.

United States

NovaRock Biotherapeutics is an innovative and dynamic biotech company focusing on the development of antibody therapies for cancer and autoimmune diseases. NovaRock was founded in January 2018 in Princeton, New Jersey by a team of veteran scientists with proven track records in the advancement of biologics from discovery to commercialization.

NovaRock Biotherapeutics

Company Details